Phase 1 Clinical Study of TS-071 in Healthy Male Adults (Repeated Administration)
Phase 1
- Conditions
- Healthy Japanese male subjects
- Registration Number
- JPRN-jRCT2080222305
- Lead Sponsor
- Taisho Pharmaceutical co., LTD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- Male
- Target Recruitment
- 24
Inclusion Criteria
Healthy Japanese male subjects
etc.
Exclusion Criteria
Subjects with cardiovascular disorder, hepatic/biliary disorder, gastrointestinal disorder, urological disorder, renal disorder, endocrine disorder, immunological disorder, malignant tumor, diabetes mellitus, abnormal glucose tolerance, or respiratory disorder (such as pulmonary disease)
etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pharmacokinetic parameters, amounts of urinary glucose excretion, etc.
- Secondary Outcome Measures
Name Time Method